

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 0,25mg | 360 pills | A$1.40 | A$591.80 A$503.03 Best Price | |
| 0,25mg | 180 pills | A$1.44 | A$305.01 A$259.26 | |
| 0,25mg | 120 pills | A$1.53 | A$216.37 A$183.91 | |
| 0,25mg | 90 pills | A$1.62 | A$172.05 A$146.24 | |
| 0,25mg | 60 pills | A$1.77 | A$125.12 A$106.35 | |
| 0,25mg | 30 pills | A$2.08 | A$72.97 A$62.03 | |
| 0,5mg | 360 pills | A$1.77 | A$748.23 A$636.00 | |
| 0,5mg | 180 pills | A$1.86 | A$393.66 A$334.61 | |
| 0,5mg | 120 pills | A$2.04 | A$286.76 A$243.75 | |
| 0,5mg | 90 pills | A$2.22 | A$234.62 A$199.43 | |
| 0,5mg | 60 pills | A$2.46 | A$174.65 A$148.46 | |
| 0,5mg | 30 pills | A$2.95 | A$104.26 A$88.62 | |
| 1mg | 360 pills | A$2.84 | A$1,201.88 A$1,021.60 | |
| 1mg | 180 pills | A$3.10 | A$656.98 A$558.43 | |
| 1mg | 120 pills | A$3.46 | A$487.52 A$414.39 | |
| 1mg | 90 pills | A$3.81 | A$404.09 A$343.47 | |
| 1mg | 60 pills | A$4.34 | A$307.62 A$261.48 | |
| 1mg | 30 pills | A$5.25 | A$185.08 A$157.32 | |
| 2mg | 360 pills | A$3.55 | A$1,501.71 A$1,276.45 Popular | |
| 2mg | 180 pills | A$4.01 | A$849.91 A$722.43 | |
| 2mg | 120 pills | A$4.57 | A$643.95 A$547.35 | |
| 2mg | 90 pills | A$5.10 | A$539.66 A$458.71 | |
| 2mg | 60 pills | A$6.16 | A$435.37 A$370.07 | |
| 2mg | 30 pills | A$8.29 | A$291.98 A$248.18 |
Ropinirole is a non-ergot dopamine agonist that selectively stimulates central dopamine D2-like receptors (D2, D3, and to a lesser extent D4) to mimic the actions of endogenous dopamine. This pharmacologic activity supports dopaminergic signaling in pathways affected by Parkinson disease and may improve motor symptoms and sleep-related symptoms in restless legs syndrome. Ropinirole is used as symptomatic treatment and is often prescribed when patients require additional dopaminergic support beyond other therapies.
Clinically, ropinirole is formulated in immediate- and extended-release oral forms, allowing flexible dosing schedules. It is absorbed orally and reaches steady-state through regular dosing. The drugβs effect depends on intact receptor activity in the central nervous system and is influenced by renal and hepatic function, age, and concomitant medications.
Ropinirole is approved for the management of Parkinson disease, including as initial therapy or as an adjunct to levodopa in motor fluctuations. It is also approved for moderate to severe restless legs syndrome where symptoms impair sleep and quality of life.
In practice, ropinirole may be used alone or in combination with other antiparkinsonian agents. Dosing is individualized and adjusted based on response and tolerability. The drug helps reduce tremor, stiffness, and bradykinesia, and can lessen uncomfortable limb sensations in RLS, typically during the evening or night.
Start with the lowest effective dose and titrate slowly under medical supervision. For Parkinson disease, common starting regimens begin with small divided doses early in the day and increase gradually as tolerated. For restless legs syndrome, dosing is adjusted to provide symptom relief in the evening. Do not alter the dose without physician approval.
Meal timing can influence stomach comfort. Ropinirole may be taken with food if GI upset occurs; taking it with meals does not significantly affect the overall benefit, but large or high-fat meals can delay absorption. Swallow tablets whole; do not crush or chew extended-release formulations unless directed by a clinician. Swallow the immediate-release form with water before or after meals as prescribed.
Missed doses: if you miss a dose, take it as soon as you remember unless it is nearly time for the next scheduled dose. Do not double the dose to catch up. If you are close to the next dose, skip the missed dose and resume your regular schedule. If vomiting occurs after a dose, contact your clinician before taking a new dose.
Storage: store at room temperature, away from moisture and heat. Keep all medicines out of reach of children. Check the expiration date on the package and discard any outdated product. Do not store in bathrooms or vehicles where temperature can fluctuate.
Common side effects include nausea, dizziness, drowsiness, fatigue, and dry mouth. Some people feel lightheaded when standing, especially after doses. Mood changes, confusion, or trouble sleeping can occur. Movement-related urges such as an increased drive to gamble, binge-eating, or sexual activity have been reported with dopamine agonists and should be reported to a clinician.
Less common but more serious effects include sudden sleep episodes without warning, severe confusion, fainting, fast or irregular heartbeat, chest pain, or signs of an allergic reaction like rash or swelling. If you notice swelling in the legs or ankles, unusual bleeding or bruising, yellowing of the skin or eyes, or dark urine, seek medical attention promptly. Contact a healthcare professional if you develop worsening motor symptoms or abnormal movements that interfere with daily life.
Contact your prescriber if you experience persistent or worsening side effects that affect daily function. Seek urgent care for chest pain, severe shortness of breath, fainting, or signs of an allergic reaction. If you become pregnant or plan to become pregnant, discuss treatment options with your clinician.
Maintain regular follow-up appointments to monitor response, adjust dosage, and assess for compulsive behaviors or other neuropsychiatric effects. Do not stop ropinirole abruptly; abrupt withdrawal can worsen Parkinson symptoms and cause other complications. If you start new medications, inform your healthcare provider to evaluate potential interactions.
14β21 days. Free from A$285.95 .
5β9 days. A$42.89
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
